Related Experiment Video

Updated: Jul 18, 2026

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
09:57

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens

Published on: February 14, 2011

Mucormycosis in a patient with low risk myelodysplasia treated with anti-TNF-alpha

A Keijzer1, P van der Valk, G J Ossenkoppele

  • 1VU-University Medical centre Amsterdam, department of haematology, de Boelelaan 1117, BR 240,1081 HV, Amsterdam, The Netherlands. A.Keijzer@vumc.nl

Haematologica
|December 30, 2006
PubMed

Insights

Accelerated cell death is key in myelodysplasia. Anti-tumor necrosis factor-alpha (TNF-alpha) therapy, while explored, carries infection risks, as seen in a patient with invasive mucormycosis.

Area of Science:

  • Hematology
  • Immunology
  • Oncology

Background:

  • Myelodysplastic syndromes (MDS) are characterized by ineffective hematopoiesis and increased apoptosis.
  • Tumor necrosis factor-alpha (TNF-alpha) overexpression is implicated in MDS pathogenesis, driving cell death.
  • Anti-TNF-alpha therapies are being investigated as a potential treatment for MDS.

Observation:

  • A patient with low-risk myelodysplastic syndrome received anti-TNF-alpha treatment.
  • The patient developed an opportunistic infection during the course of treatment.

Findings:

  • The patient succumbed to invasive mucormycosis, a rare fungal infection.
  • This case highlights a severe adverse event associated with anti-TNF-alpha therapy in MDS.

Implications:

  • Anti-TNF-alpha therapy requires careful risk-benefit assessment in MDS patients.
  • Vigilance for opportunistic infections is crucial during anti-TNF-alpha treatment for myelodysplasia.
  • Further research is needed to understand and mitigate infection risks associated with TNF-alpha inhibition in hematological malignancies.

More Related Videos

Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro07:51

Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro

Published on: March 18, 2019

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...